Dear Doctor Name, We are excited to introduce our Augmented Reality (AR) experience, providing our users a closer perspective of the intricate details of our advanced dialysis machines. Our immersive AR experience allows you to explore our state-of-the-art devices from all angles, zooming in and rotating to observe every component. Simply click on the link below using your computer or mobile device to embark on an immersive journey through the world of Fresenius Medical Care dialysis machines. We believe that this AR experience will revolutionize the way you engage with our products, empowering you with a deeper understanding and supporting your decision-making processes. Stay tuned for further updates as we continue to enhance this AR experience and shape the future of dialysis treatment. For more information on 5008S , visit our website here or contact us at fmc.sg@fmc-asia.com 1. Source: Fresenius Medical Care Internal Process Step Analysis (unpublished data on file). Note: Based on this assessment, we have identified 146 daily process steps in a reference facility. Up to 49% of these process steps can be improved versus traditional process steps. Comparison based upon utilizing the 5008S, Therapy Monitor, IDMS, AquaSENS(basic version without options), AquaBplus, CDS3 central concentrate delivery, motorized patient chairs / beds, integrated patient weighing scales and support services -versus use of standard 4008 S dialysis machine and a standard AquaBDuo water treatment device with no integration of digital solutions. Quantification of process steps and potential process step improvements are contextual and dependent upon the baseline set-up of individual clinics. 2. Reduction of therapy documentation effort in conjunction with TDMS (Note: TDMS must be purchased separately) All contents of this material are for informational purposes only and provided by the Fresenius Medical Care group of companies without warranties of any kind. None of the information is a substitute for professional medical or health advice, examination or recommended treatments. The availability of products or services mentioned in this material is subject to regulatory requirements and product or service registration status in each country, and products and technical specifications may change without notice. The above email has been sent as part of an ongoing discussion between your organisation and Fresenius Medical Care Singapore Pte Ltd. Should you receive this email by mistake, or wish to update your communication preference, or are not interested in receiving emails like this, please reply to the sender of this message directly.You may also refer to our Privacy Policy at https://www.freseniusmedicalcare.sg/en-sg/privacy-policy.